These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11025183)

  • 1. Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods.
    Bonapace CR; White RL; Friedrich LV; Bosso JA
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):43-50. PubMed ID: 11025183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
    Ozseven AG; Sesli Çetin E; Ozseven L
    Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.
    White RL; Burgess DS; Manduru M; Bosso JA
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1914-8. PubMed ID: 8843303
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
    Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cluster of nosocomial cross-infection due to multiple antibiotic-resistant Acinetobacter baumannii: Characterization of the strain and antibiotic susceptibility studies.
    Traub WH; Geipel U; Schwarze I; Bauer D
    Chemotherapy; 1999; 45(5):349-59. PubMed ID: 10473923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill.
    Burgess DS; Hastings RW
    Diagn Microbiol Infect Dis; 2000 Sep; 38(1):37-41. PubMed ID: 11025182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A meta-analysis of in vitro antibiotic synergy against Acinetobacter baumannii.
    March GA; Bratos MA
    J Microbiol Methods; 2015 Dec; 119():31-6. PubMed ID: 26415528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates.
    Jung R; Husain M; Choi MK; Fish DN
    Antimicrob Agents Chemother; 2004 Mar; 48(3):1055-7. PubMed ID: 14982809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of gatifloxacin alone and in combination with cefepime, meropenem, piperacillin and gentamicin against multidrug-resistant organisms.
    Dawis MA; Isenberg HD; France KA; Jenkins SG
    J Antimicrob Chemother; 2003 May; 51(5):1203-11. PubMed ID: 12697632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations.
    Marques MB; Brookings ES; Moser SA; Sonke PB; Waites KB
    Antimicrob Agents Chemother; 1997 May; 41(5):881-5. PubMed ID: 9145838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual trends in antibiotic resistance of nosocomial Acinetobacter baumannii strains and the effect of synergistic antibiotic combinations.
    Tatman-Otkun M; Gürcan S; Ozer B; Shokrylanbaran N
    New Microbiol; 2004 Jan; 27(1):21-8. PubMed ID: 14964402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter baumannii.
    Sopirala MM; Mangino JE; Gebreyes WA; Biller B; Bannerman T; Balada-Llasat JM; Pancholi P
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4678-83. PubMed ID: 20713678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Vitro Activity of Various Antibiotics in Combination with Tigecycline Against Acinetobacter baumannii: A Systematic Review and Meta-Analysis.
    Li J; Yang X; Chen L; Duan X; Jiang Z
    Microb Drug Resist; 2017 Dec; 23(8):982-993. PubMed ID: 28437233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antibiotic synergy in extensively drug-resistant Acinetobacter baumannii: the effect of testing by time-kill, checkerboard, and Etest methods.
    Tan TY; Lim TP; Lee WH; Sasikala S; Hsu LY; Kwa AL
    Antimicrob Agents Chemother; 2011 Jan; 55(1):436-8. PubMed ID: 20956606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Various antibiotic combinations against carbapenem resistant Acinetobacter baumannii infections and in vitro synergy test results (2002-2016)].
    Zarakolu P; Ayaz ÇM; Metan G
    Mikrobiyol Bul; 2018 Apr; 52(2):190-197. PubMed ID: 29933736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
    Tan TY; Ng LS; Tan E; Huang G
    J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak.
    Appleman MD; Belzberg H; Citron DM; Heseltine PN; Yellin AE; Murray J; Berne TV
    Antimicrob Agents Chemother; 2000 Apr; 44(4):1035-40. PubMed ID: 10722508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii.
    Martinez-Martinez L; Rodriguez G; Pascual A; Suárez AI; Perea EJ
    J Antimicrob Chemother; 1996 Dec; 38(6):1107-8. PubMed ID: 9023661
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation of Checkerboard Synergy Testing with Time-Kill Analysis and Clinical Outcomes of Extensively Drug-Resistant Acinetobacter baumannii Respiratory Infections.
    Bremmer DN; Bauer KA; Pouch SM; Thomas K; Smith D; Goff DA; Pancholi P; Balada-Llasat JM
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6892-6895. PubMed ID: 27527089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.